BANK VONTOBEL/CALL/ELI LILLY & CO/660/0.1/21.06.24 Share Price

Warrant

DE000VM1HAJ2

Market Closed - Deutsche Boerse AG 19:03:17 14/06/2024 BST
20.56 EUR +0.44% Intraday chart for BANK VONTOBEL/CALL/ELI LILLY & CO/660/0.1/21.06.24
Current month+42.19%
1 month+110.01%
Date Price Change
14/06/24 20.56 +0.44%
13/06/24 20.47 +8.25%
12/06/24 18.91 -0.63%
11/06/24 19.03 +0.42%
10/06/24 18.95 +4.58%

Delayed Quote Deutsche Boerse AG

Last update June 14, 2024 at 07:03 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ELI LILLY AND COMPANY
IssuerLogo Issuer Vontobel Vontobel
WKN VM1HAJ
ISINDE000VM1HAJ2
Date issued 22/08/2023
Strike 660 $
Maturity 21/06/2024 (6 Days)
Parity 10 : 1
Emission price 2.15
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 21.44
Lowest since issue 1.74
Delta1x
Omega 3.993
Premium0.09x
Gearing4.01x
Moneyness 1.331
Difference Strike -218.5 $
Difference Strike %-33.10%
Spread 0.02
Spread %0.10%
Intrinsic value 20.41

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
878.4 USD
Average target price
855.4 USD
Spread / Average Target
-2.63%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW